Holen Sie sich die Stockscreener-App
22.52
0.44%
-0.10
Schlusskurs vom Vortag:
$22.62
Offen:
$22.67
24-Stunden-Volumen:
1.25M
Relative Volume:
0.85
Marktkapitalisierung:
$2.88B
Einnahmen:
$2.25B
Nettoeinkommen (Verlust:
$27.39M
KGV:
134.21
EPS:
0.1678
Netto-Cashflow:
$136.77M
1W Leistung:
+8.01%
1M Leistung:
+10.55%
6M Leistung:
-4.17%
1J Leistung:
-11.79%
1-Tages-Spanne:
$22.39
$22.80
1-Wochen-Bereich:
$20.84
$22.80
52-Wochen-Spanne:
$18.91
$28.82
Privia Health Group Inc Stock (PRVA) Company Profile
Firmenname
Privia Health Group Inc
Sektor
Branche
Telefon
571-366-8850
Adresse
950 N. GLEBE RD., SUITE 700, ARLINGTON
Compare PRVA vs VEEV, BTSG, TEM, HNGE, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
22.52 | 2.88B | 2.25B | 27.39M | 136.77M | 0.1678 |
VEEV
Veeva Systems Inc
|
310.36 | 50.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
60.87 | 12.04B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
64.72 | 11.75B | 1.36B | -302.91M | -219.93M | -1.7182 |
HNGE
Hinge Health Inc
|
99.16 | 8.00B | 646.34M | -512.40M | 202.76M | -6.6871 |
HQY
Healthequity Inc
|
92.03 | 7.61B | 1.34B | 230.70M | 440.96M | 2.6695 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Fortgesetzt | Jefferies | Buy |
| 2024-02-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-03-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-02-03 | Eingeleitet | Goldman | Buy |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-12-08 | Eingeleitet | UBS | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-05-03 | Eingeleitet | BofA Securities | Buy |
| 2022-04-28 | Eingeleitet | BTIG Research | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2022-02-22 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-01-03 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-05-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-05-24 | Eingeleitet | Credit Suisse | Outperform |
| 2021-05-24 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-24 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-24 | Eingeleitet | Truist | Buy |
| 2021-05-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Privia Health Group Inc Aktie (PRVA) Neueste Nachrichten
At 8 a.m. Nov. 5, managers will discuss Privia Health's results. - Stock Titan
No voting power accompanies Abigail P. Johnson's reported stake in Privia Health (PRVA). - Stock Titan
Option Care Health (Nasdaq:OPCH)Stock Analysis - Simply Wall Street
Privia Health Group, Inc. (PRVA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Privia Health Group stock hits 52-week low at 19.52 USD - Investing.com
What Today's smallcap stocks Session Means for Privia Health? - kalkinemedia.com
Why Is Privia Health Group (PRVA) a Stock to Watch Today? - kalkinemedia.com
Responsive Playbooks and the PRVA Inflection - Stock Traders Daily
Healthcare Technology for Providers Stocks Q2 Teardown: Privia Health (NASDAQ:PRVA) Vs The Rest - Yahoo Finance
Why Does Privia Health (NASDAQ:PRVA) Stand Out This Session? - Kalkine Media
Healthcare Technology for Providers Stocks Q2 Teardown: Privia Health (NASDAQ:PRVA) Vs The Rest - TradingView
Privia Health Group Inc. (PRVA) Peer Comparison – Compare with Others - valueresearchonline.com
PGIM Securitized Income ETF (PINC) Stock Price, News & Analysis - Stock Titan
What Is Shaping Interest in Privia Health Stock? (NASDAQ:PRVA) - Kalkine Media
Adam Boehler Discloses Investment in Privia Health Group with 5.07% Stake - TradingView
New investor group tops 5% stake in Privia Health (NASDAQ: PRVA) - Stock Titan
What Is Shaping Interest in Privia Health Stock? (NASDAQ:PRVA) - Kalkine Media
(PRVA) Volatility Zones as Tactical Triggers - Stock Traders Daily
Why Is Privia Health Getting Attention? - Kalkine Media
Price to sales forward of Privia Health Group, Inc. – NASDAQ:PRVA - TradingView
Enterprise value to revenue forward of Privia Health Group, Inc. – NASDAQ:PRVA - TradingView
Privia Health (PRVA): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Should Stronger 2026 Guidance and New Board Expertise Require Action From Privia Health Group (PRVA) Investors? - simplywall.st
Should Stronger 2026 Guidance and New Board Expertise Require Action From Privia Health Group (PRVA) Investors? - simplywall.st
PRVA Q2 2026 Earnings: Modest EPS Beat Signals Steady Execution in Value-Based CareManagement Tone Analysis - vinanet.vn
Privia Health Appoints Dr. Opella Ernest to Board of Directors Effective September 2026 - Kalkine Media
Privia Health adds Dr. Opella Ernest to board of directors - Investing.com
Privia Health adds Dr. Opella Ernest to board of directors By Investing.com - Investing.com Nigeria
Privia Health adds Dr. Opella Ernest to board of directors By Investing.com - Investing.com South Africa
Form 8K Privia Health Group Inc For: 18 August By Investing.com - Investing.com Nigeria
Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors - The Manila Times
Privia Health adds Dr. Opella Ernest to board of directors By Investing.com - Investing.com India
Form 8K Privia Health Group Inc For: 18 August By Investing.com - Investing.com Canada
Privia Health Group Appoints Opella Ernest, M.D. to Board of Directors - Quiver Quantitative
Privia Health adds Dr. Opella Ernest to board of directors By Investing.com - Investing.com UK
A 20-year healthcare executive is set to join Privia Health's board - Stock Titan
Privia (PRVA) Erases Recent Gains with -2.27% Plunge 2026-08-18Donchian Channel - vinanet.vn
Bank of America Corp DE Cuts Holdings in Privia Health Group, Inc. $PRVA - MarketBeat
Privia Health (PRVA) Edges Higher to $22.0, Holding Above Key SupportTotal Put Call - vinanet.vn
GSA Capital Partners LLP Invests $1.67 Million in Privia Health Group, Inc. $PRVA - MarketBeat
OneDigital Investment Advisors LLC Purchases New Stake in Privia Health Group, Inc. $PRVA - MarketBeat
ETFs Investing in Privia Health Group, Inc. Stocks - TradingView
Oppenheimer Asset Management Inc. Purchases New Stake in Privia Health Group, Inc. $PRVA - MarketBeat
PRVA|Privia Health Group Inc|Price:22.000|Chg%:+0.240 - TradingKey
Privia Health (PRVA) Climbs 1.1% to $22.0, Testing Key Resistance at $23.1Standard Deviation - vinanet.vn
The Top 5 Analyst Questions From Privia Health’s Q2 Earnings Call - Yahoo Finance
Privia Health’s (PRVA) Guidance Keeps Rising, So Is The Stock Keeping Pace? - Yahoo Finance
Privia Health Group, Inc. (PRVA) Stock Forecasts - Yahoo! Finance Canada
Privia Health (PRVA) Q2 2026 Earnings Call Transcript - The Globe and Mail
The Top 5 Analyst Questions From Privia Health’s Q2 Earnings Call - StockStory
Finanzdaten der Privia Health Group Inc-Aktie (PRVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Privia Health Group Inc-Aktie (PRVA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mountcastle David | Officer |
Jul 09 '26 |
Proposed Sale |
27.67 |
21,275 |
588,603 |
0 |
| Mountcastle David | Officer |
Jul 07 '26 |
Proposed Sale |
27.57 |
600 |
16,539 |
0 |
| Mountcastle David | EVP & Chief Financial Officer |
Jul 07 '26 |
Sale |
27.57 |
600 |
16,542 |
186,128 |
| Morris Matthew Shawn | Director |
Jul 06 '26 |
Sale |
27.24 |
53,722 |
1,463,387 |
68,188 |
| Morris Matthew Shawn | Director |
Jul 06 '26 |
Option Exercise |
2.00 |
53,722 |
107,444 |
130,373 |
| Mountcastle David | Officer |
Jul 02 '26 |
Proposed Sale |
27.50 |
24,734 |
680,188 |
0 |
| Morris Matthew Shawn | Director |
Jul 02 '26 |
Option Exercise |
2.00 |
59,037 |
118,074 |
135,688 |
| Morris Matthew Shawn | Director |
Jul 02 '26 |
Sale |
27.33 |
59,037 |
1,613,481 |
76,651 |
| Mountcastle David | EVP & Chief Financial Officer |
Jul 02 '26 |
Sale |
27.50 |
24,734 |
680,185 |
186,728 |
| Morris Matthew Shawn | Director |
Jul 01 '26 |
Sale |
26.70 |
82,675 |
2,207,728 |
76,651 |
11.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):